FN2 Earnings Intelligence
Molina Healthcare, Inc. ratios (quarterly)
Molina Healthcare, Inc. (MOH) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $4,856 | $4,499 | $4,221 | $5,314 | $4,985 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $11,147 | $11,427 | $11,477 | $10,796 | $10,874 | $10,858.5 | $11,951.2 |
| % Growth | - | - | - | - | - | -5.4% | - |
| Gross Profit | $1,149 | $1,039 | $797 | $902 | $804 | - | - |
| % Margin | 10.3% | 9.1% | 6.9% | 8.4% | 7.4% | - | - |
| EBITDA | $481 | $431 | $182 | $122 | $185 | - | - |
| % Margin | 4.3% | 3.8% | 1.6% | 1.1% | 1.7% | - | - |
| Net Income | $298 | $255 | $79 | $14 | $60 | - | - |
| % Margin | 2.7% | 2.2% | 0.7% | 0.1% | 0.6% | - | - |
| Diluted EPS | $5.45 | $4.75 | $1.51 | $0.27 | $1.19 | $0.84 | $0.54 |
| % Growth | - | - | - | - | - | -44.0% | - |
| Operating Cash Flow | $190 | - | - | $1,082 | - | - | - |
| CapEx | $22 | - | - | $27 | - | - | - |
| Free Cash Flow | $168 | - | - | $1,055 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $11,147 | $11,427 | $11,477 | $10,796 | $10,874 | $10,858.5 | $11,951.2 |
| Gross Profit | $1,149 | $1,039 | $797 | $902 | $804 | - | - |
| EBITDA | $481 | $431 | $182 | $122 | $185 | - | - |
| Net Income | $298 | $255 | $79 | $14 | $60 | - | - |
| Diluted EPS | $5.45 | $4.75 | $1.51 | $0.27 | $1.19 | $0.84 | $0.54 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4,856 | $4,499 | $4,221 | $5,314 | $4,985 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $3,574 | $3,375 | $3,664 | $3,767 | $3,769 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $190 | - | - | $1,082 | - |
| Capital Expenditure | $22 | - | - | $27 | - |
| Free Cash Flow | $168 | - | - | $1,055 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 10.3% | 9.1% | 6.9% | 8.4% | 7.4% |
| EBITDA Margin | 4.3% | 3.8% | 1.6% | 1.1% | 1.7% |
| Net Margin | 2.7% | 2.2% | 0.7% | 0.1% | 0.6% |
| FCF Margin | 1.5% | - | - | 9.8% | - |
| Diluted EPS Growth | - | - | - | - | - |